Free Trial

AIM ImmunoTech (AIM) SEC Filings & 10K Form

$0.40
-0.01 (-2.45%)
(As of 05/23/2024 ET)

Recent AIM ImmunoTech SEC Filings

DateFilerForm TypeView
05/07/2024
7:30 AM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 AM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
11:16 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form EFFECT
05/01/2024
3:35 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 424B5
03/29/2024
8:18 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
12:52 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
12:54 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
12:30 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
BRYAN NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:37 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form D/A
02/09/2024
2:47 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
12:42 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:45 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
7:15 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
11/20/2023
4:29 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
11/20/2023
8:05 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
KELLNER TED D (Filed by)
Form DFAN14A
11/20/2023
6:30 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
11/16/2023
8:21 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
KELLNER TED D (Filed by)
Form DFAN14A
11/15/2023
6:30 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
3:15 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
11/08/2023
7:45 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
5:03 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
11/06/2023
8:09 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
Form DEFC14A
10/24/2023
4:00 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form PRER14A
10/13/2023
3:57 PM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
KELLNER TED D (Filed by)
Form PREC14A
10/10/2023
8:00 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
Form PREC14A
09/29/2023
2:29 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
6:00 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
8:10 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
11:52 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
KELLNER TED D (Filed by)
Form DFAN14A
08/28/2023
5:36 AM
AIM ImmunoTech Inc. (Subject)
AIM ImmunoTech (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
08/25/2023
1:26 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
12:52 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:30 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form DEFA14A
08/23/2023
7:51 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
6:00 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
6:20 PM
AIM ImmunoTech Inc. (Issuer)
AIM ImmunoTech (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:45 PM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
07/03/2023
7:42 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/30/2023
6:00 AM
AIM ImmunoTech Inc. (Filer)
AIM ImmunoTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:AIM) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners